Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - February 19, 2026 12 Q1 2026 BULLSEYE CHARTS This resource is supported by Learn More UBC partners with biopharma to modernize evidence… Source RELATED ARTICLESMORE FROM AUTHOR A Closer Look at Definium’s Phase 3 LSD for GAD Readout Weekly Psychedelic Policy Briefing: August 23, 2026 Who Gets to Heal?
